High incidence of naevi-associated BRAF wild-type melanoma and dysplastic naevi under treatment with the class I BRAF inhibitor vemurafenib.
| Image |  |
|---|---|
| Description | scientific article published in September 2014 |
| Author/s |
author: Sven Quist |
| Publication date | September 1, 2014 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |